Can PET eradicate irradiation in PMBCL?

Abstract

In this issue of Blood, Hayden et al elegantly describe real-world data from their positron emission tomography (PET)-adapted treatment approach toward consolidative radiotherapy (RT) after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) in primary mediastinal B-cell lymphoma (PMBCL).